Literature DB >> 33611132

Effects of brief stress management interventions on distress and leukocyte nuclear factor kappa B expression during primary treatment for breast cancer: A randomized trial.

Alain Diaz1, Chloe J Taub2, Marc E Lippman3, Michael H Antoni4, Bonnie B Blomberg5.   

Abstract

BACKGROUND: A randomized controlled trial (RCT) of 5-week stress management interventions teaching cognitive behavioral therapy (CBT) or relaxation training (RT) techniques showed decreases in stress and serum inflammatory markers over 12 months in women undergoing treatment for breast cancer (BCa). To understand the molecular mechanisms involved, we examined the effects of these interventions on the transcription factor NF-κB DNA binding activity in leukocytes in parallel with circulating inflammatory markers, stress management skill efficacy and multiple distress indicators.
METHODS: This is a secondary analysis using blood samples of 51 BCa patients (Stage 0-III) with high cancer-specific distress selected from a completed RCT (NCT02103387). Women were randomized to one of three conditions, CBT, RT or health education control (HE). Blood samples and self-reported distress measures (Affects Balance Scale-Negative Affect [ABS-NA], Impact of Events Scale-hyperarousal [IES-H] and intrusive thoughts [IES-I]) were collected at baseline (T0) and 12-month follow-up (T2). Self-reported distress measures and perceived stress management skills (PSMS) were also measured immediately post-intervention (baseline + 2 months: T1). Repeated measures analyses compared changes in distress and NF-κB expression among conditions, controlling for age, stage of cancer, days from surgery to baseline, and receipt of chemotherapy and radiation. Regression analyses related T0 to T2 change in NF-κB expression with T0 to T1 changes in self-reported PSMS and distress measures. Exploratory regression analyses also associated change in NF-κB expression with change in serum cytokines (IL-1β, IL-6 and TNF-α); and s100A8/A9, a circulating inflammatory marker important in breast cancer progression.
RESULTS: There was a significant condition (CBT/RT, HE)xtime (T0, T2) effect on NF-κB, F(1, 39)= 5.267, p = 0.036, wherein NF-κB expression significantly increased over time for HE but did not change for RT or CBT. Greater increases in PSMS from T0 to T1 were associated with less increase in NF-κB expression over 12 months (β = -0.426, t(36) = -2.637, p = 0.048). We found that women assigned to active intervention (CBT/RT) had significant decreases in ABS-NA (F(1, 40)= 6.537, p = 0.028) and IES-I (F(1, 40)= 4.391, p = 0.043) from T0 to T1 compared to women assigned to HE, who showed no change over time (p's > 0.10). For women assigned to CBT or RT, lower NF-κB expression at T2 was related to less ABS-NA, IES-H, and IES-I, all p's < 0.05, although T0-T1 change in distress was not related to T0-T2 change in NF-κB expression for those in an active intervention.
CONCLUSIONS: Brief CBT or RT stress management interventions can mitigate increases in pro-inflammatory leukocyte NF-κB binding over 12 months of primary treatment in highly distressed BCa patients. These effects are likely brought about by improved stress management skills.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Breast cancer; Cognitive-behavioral; Distress; NF-κB; Relaxation training; Stress management

Mesh:

Substances:

Year:  2021        PMID: 33611132      PMCID: PMC9295339          DOI: 10.1016/j.psyneuen.2021.105163

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.693


  42 in total

1.  Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes.

Authors:  Nagesha A S Rao; Melysia T McCalman; Panagiotis Moulos; Kees-Jan Francoijs; Aristotelis Chatziioannou; Fragiskos N Kolisis; Michael N Alexis; Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  Genome Res       Date:  2011-07-12       Impact factor: 9.043

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 3.  Stress, adaptation, and disease. Allostasis and allostatic load.

Authors:  B S McEwen
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

4.  Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer.

Authors:  Michael H Antoni; Sarah R Wimberly; Suzanne C Lechner; Aisha Kazi; Tammy Sifre; Kenya R Urcuyo; Kristin Phillips; Roselyn G Smith; Vida M Petronis; Sophie Guellati; Kurrie A Wells; Bonnie Blomberg; Charles S Carver
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

Review 5.  A biobehavioral model of cancer stress and disease course.

Authors:  B L Andersen; J K Kiecolt-Glaser; R Glaser
Journal:  Am Psychol       Date:  1994-05

6.  Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis.

Authors:  Michael H Antoni; Laura C Bouchard; Jamie M Jacobs; Suzanne C Lechner; Devika R Jutagir; Lisa M Gudenkauf; Charles S Carver; Susan Lutgendorf; Steven W Cole; Marc Lippman; Bonnie B Blomberg
Journal:  Psychoneuroendocrinology       Date:  2016-09-24       Impact factor: 4.905

7.  Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B.

Authors:  Mylin A Torres; Thaddeus W Pace; Tian Liu; Jennifer C Felger; Donna Mister; Gregory H Doho; Jordan N Kohn; Andrea M Barsevick; Qi Long; Andrew H Miller
Journal:  Cancer       Date:  2013-03-19       Impact factor: 6.860

8.  Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls.

Authors:  Jasper Tromp; Liselotte M Boerman; Iziah E Sama; Saskia W M C Maass; John H Maduro; Yoran M Hummel; Marjolein Y Berger; Geertruida H de Bock; Jourik A Gietema; Annette J Berendsen; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2020-02-20       Impact factor: 15.534

9.  Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis.

Authors:  Hae-Young Kim
Journal:  Restor Dent Endod       Date:  2013-02-26

Review 10.  Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity.

Authors:  Afsar U Ahmed; Bryan R G Williams; Gregory E Hannigan
Journal:  Biomolecules       Date:  2015-11-11
View more
  5 in total

1.  Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast Cancer.

Authors:  Chloe J Taub; Alain Diaz; Bonnie B Blomberg; Devika R Jutagir; Hannah M Fisher; Lisa M Gudenkauf; Marc E Lippman; Barry I Hudson; Michael H Antoni
Journal:  Psychosom Med       Date:  2022-07-28       Impact factor: 3.864

2.  Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.

Authors:  Molly E Ream; Emily A Walsh; Jamie M Jacobs; Chloe Taub; Marc Lippman; Natasha Schaefer-Solle; Steven A Safren; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2021-08-19       Impact factor: 4.624

Review 3.  Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes.

Authors:  Aeson Chang; Erica K Sloan; Michael H Antoni; Jennifer M Knight; Rachel Telles; Susan K Lutgendorf
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

Review 4.  Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?

Authors:  A Costanza; A Amerio; A Aguglia; G Serafini; M Amore; R Hasler; J Ambrosetti; G Bondolfi; G Sampogna; I Berardelli; A Fiorillo; M Pompili; K D Nguyen
Journal:  Neurosci Biobehav Rev       Date:  2022-03-12       Impact factor: 9.052

5.  Brief Post-Surgical Stress Management Reduces Pro-Inflammatory Cytokines in Overweight and Obese Breast Cancer Patients Undergoing Primary Treatment.

Authors:  Molly Ream; Estefany Saez-Clarke; Chloe Taub; Alain Diaz; Daniela Frasca; Bonnie B Blomberg; Michael H Antoni
Journal:  Front Biosci (Landmark Ed)       Date:  2022-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.